NCT05523037View on ClinicalTrials.gov

Comparison of the Effect of Remimazolam With Sevoflurane on Postanesthetic Shivering

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

January 2, 2022

Primary Completion Date

July 30, 2022

Study Completion Date

August 15, 2022

Conditions
Anesthesia; Hypothermia
Interventions
DRUG

Sevoflurane

For the maintenance of anesthesia, the end-tidal concentration of 1 minimum alveolar concentration (MAC) sevoflurane and the concentration was adjusted by 1% stepwise titration

DRUG

Remimazolam

For the maintenance of anesthesia, 1-2 mg.kg-1.h-1 of remimazolam was continuously infused.

Trial Locations (1)

54538

Wonkwag UH, Iksan

All Listed Sponsors
lead

Wonkwang University Hospital

OTHER

NCT05523037 - Comparison of the Effect of Remimazolam With Sevoflurane on Postanesthetic Shivering | Biotech Hunter | Biotech Hunter